Geron Corp
GERN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886744
In the last 90 days, Geron Corp insiders filed 2 open-market purchases and 0 sales; 261 institutions reported holding it in 13F filings for Q2 2026, worth $610.5M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 17, 2026
- $644.2M
- Insider buysLast 90 days, $62.1K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +6 vs. previous quarter
- 261
- 13F valueReported value at the end of Q2 2026
- $610.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$83.5M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $60.2M
- +27.4% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 67.0M
- Shares sold short
- Change
- −7.66M
- −10.3% vs. previous
- Days to cover
- 3.92
- At average daily volume
Superinvestors holding GERN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding GERN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Geron Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 (view filing)4:30 PM ET | Nov 16 | Same day | Williams TimothyEVP and Chief Legal Officer | PPurchase | +12.0K | $0.94 | +$11.3K | New position12.0K after | |
| Nov 16, 2026 (view filing)4:30 PM ET | Nov 13 | 3 days | Semerjian HaroutPresident & CEO | PPurchase | +53.5K | $0.95 | +$50.8K | New position53.5K after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −9.86K | $1.94 | −$19.1K | −35.8%17.6K after | |
| May 13, 2025 (view filing) | May 9 | 4 days | Lawlis V BryanDirector | PPurchase | +13.3K | $1.18 | +$15.7K | New position13.3K after | |
| Mar 3, 2025 (view filing) | Feb 27 | 4 days | Samuels Scott AlanEVP, Chief Legal Officer | PPurchase | +15.0K | $1.61 | +$24.1K | +128.4%26.7K after | |
| Mar 3, 2025 (view filing) | Feb 27 | 4 days | Scarlett John AChairman, President and CEO | PPurchase | +12.5K | $1.77 | +$22.1K | New position12.5K after | |
| Mar 3, 2025 (view filing) | Feb 27 | 4 days | Ziegler JamesEVP, Chief Commercial Officer | PPurchase | +100.0K | $1.60 | +$160.0K | New position100.0K after | |
| Jul 10, 2024 (view filing) | Jul 8 | 2 days | Grethlein Andrew JEVP, Chief Operating Officer | SSale | −674.3K | $4.56 | −$3.08M | −100.0%0 after | |
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Feller FayeEVP, Chief Medical Officer | SSale | −287.9K | $4.63 | −$1.33M | −100.0%0 after | |
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Kapur AnilEVP, Corp Strategy & CCO | SSale | −421.9K | $4.65 | −$1.96M | −100.0%0 after |
Top 10 13F holders, Q2 2026
See all 261 holdersThe largest institutional positions in Geron Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49,115,571 | $62.9M | 0.00% | +1,795,792+3.8% | Added |
| Ra Capital Management, L.P. | 42,809,751 | $54.8M | 0.48% | −20,961,615−32.9% | Reduced |
| Soleus Capital Management, L.P. | 42,808,659 | $54.8M | 1.89% | +1,300,000+3.1% | Added |
| State Street Corp | 35,856,671 | $45.9M | 0.00% | +5,359,488+17.6% | Added |
| Citadel Advisors LLC | 29,038,928 | $37.2M | 0.02% | +7,462,359+34.6% | Added |
| Vanguard Capital Management LLC | 27,250,215 | $34.9M | 0.00% | +581,186+2.2% | Added |
| Clearbridge Investments, LLC | 19,648,853 | $25.2M | 0.02% | +28,533+0.1% | Added |
| Eversept Partners, LP | 18,717,422 | $24.0M | 1.31% | −117,461−0.6% | Reduced |
| Goldman Sachs Group Inc | 16,633,368 | $21.3M | 0.00% | +5,456,777+48.8% | Added |
| Geode Capital Management, LLC | 14,555,954 | $18.6M | 0.00% | +885,169+6.5% | Added |
Holders of 5% or more of GERN
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Geron Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13G/A | 9.90%66.5M shares | 0.00 ppfrom 9.90% | Feb 16, 20217 filings | Aug 14, 2026 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 6.50%41.5M shares | +1.30 ppfrom 5.20% | Mar 3, 20262 filings | May 8, 2026 | SEC |
| State Street Corp | 13G | 5.00%31.9M shares | −0.60 ppfrom 5.60% | Feb 1, 20234 filings | Nov 10, 2026 | SEC |